Posts for Ticker ‘CUR’

Stem Cell Stocks Rise, Led By Athersys Inc. (ATHX, NBS, STEM)

Stem cell stocks (tracked in Tickerspy’s Stem Cell Stock’s Index (*RXSTM) are up over 7% today, led by Athersys Inc (NASDAQ: ATHX).  Athersys Inc. rose as high as 395% this morning following news that the company has entered into a deal with Pfizer  (NYSE: PFE) to develop Athersys’s  MultiStem, an experimental treatment for inflammatory bowel disease.  Athersys recieved an intial payment of $6 million in addition to funding for research.  Should the program be successful Athersys will recieved as much as $105 million as well as royalties from sales of the drug should it come to mark.

Other stem cell stocks received a big boost from the news.  Neostem Inc. (AMEX: NBS), which operates a operates a center for the collection and storage of stem cell, rose as high as 7.6%.  StemCells Inc. (NASDAQ: STEM), which attempts to treat organ disorders with stem cells,  climbed as high as 7.2%

Garrett W. McIntyre

Posted on: December 21, 2009 – 2:33 pm in Biotech, Pharmaceuticals, , , , , , , , , , , , ,

Stem Cell Stocks Take Off (ASTM, GERN, OPXA, STEM)

Tickerspy’s Stem Cell Stock Index (*RSXTM) took off today, rising nearly 13%.  The movement followed a release from the National Institutes of Health  (NIH) announcing that 13 embryonic stem cell lines were approved for funding.

Opexa Therapeutics Inc (NASDAQ: OPXA) led the rise in stem cell stocks, surging over 40%.  The company seeks to develop treatments to major illnesses, such as multiple sclerosis and diabetes, through stem cell research.  The company’s stock has risen 2837% off its lows for the year.

StemCells Inc (NASDAQ: STEM) rose over 30% to a high of $1.45.  The company engages in research aimed at developing treatment for organ damage using stem cells.  The company’s stock is up over 1544% off its low for the year.

Garrett W. McIntyre

Posted on: December 2, 2009 – 3:35 pm in Biotech, , , , , , , , , ,